NCT Number: NCT04253483
Phase: Phase 2
Trial Summary: This phase II trial compares high-dose rate brachytherapy and stereotactic ablative radiotherapy as monotherapy in treating patients with prostate cancer that has not spread to oth – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Rutgers, The State University of New Jersey|National Cancer Institute (NCI)
Acronym:
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives